Form 4 Filing for BELITE BIO, INC

This filing details a series of transactions by MATA NATHAN L., Chief Scientific Officer of BELITE BIO, INC, on April 22, 2026. The transactions involved the sale of American depositary shares, with the number of shares sold ranging from 21 to 257 per transaction. The sales were executed under a Rule 10b5-1 trading plan. The weighted average prices for these sales ranged from $165.64 to $173.16. Following these transactions, MATA NATHAN L. held 10,666 shares. Each American depositary share represents one ordinary share of the issuer.